Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

被引：483
|
作者：
Hallberg, Bengt [1 ]
Palmer, Ruth H. [1 ]
机构：
[1] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden
来源：
NATURE REVIEWS CANCER | 2013年 / 13卷 / 10期
基金：
瑞典研究理事会;
关键词：
ANAPLASTIC LYMPHOMA KINASE; LARGE-CELL LYMPHOMA; INFLAMMATORY MYOFIBROBLASTIC TUMOR; NPM-ALK; LUNG-CANCER; MOLECULAR CHARACTERIZATION; DOWN-REGULATION; TRUNCATED FORM; GROWTH-FACTOR; FUSION GENE;
D O I：
10.1038/nrc3580
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer (NSCLC). The common activation of ALK has led to the use of the ALK tyrosine kinase inhibitor (TKI) crizotinib in a range of patient populations and to the rapid development of second-generation drugs targeting ALK. In this Review, we discuss our current understanding of ALK function in human cancer and the implications for tumour treatment.
引用
收藏
页码：685 / 700
页数：16
相关论文
共 50 条
  • [41] The International Consortium on Systems Biology of Receptor Tyrosine Kinase Regulatory Networks
    Sakaki, Y
    Kholodenko, BN
    Hatakeyama, M
    Kitano, H
    Kolch, W
    De Meyts, P
    Yarden, Y
    Westerhoff, HV
    Wiley, HS
    IEE PROCEEDINGS SYSTEMS BIOLOGY, 2005, 152 (02): : 53 - 54
  • [42] ALK TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF NHL
    Morris, S. W.
    ANNALS OF ONCOLOGY, 2011, 22 : 113 - 113
  • [43] Expression of the ALK tyrosine kinase gene in neuroblastoma
    Lamant, L
    Pulford, K
    Bischof, D
    Morris, SW
    Mason, DY
    Delsol, G
    Mariamé, B
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (05): : 1711 - 1721
  • [44] High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
    Schulte, Johannes H.
    Bachmann, Hagen S.
    Brockmeyer, Bent
    DePreter, Katleen
    Oberthuer, Andre
    Ackermann, Sandra
    Kahlert, Yvonne
    Pajtler, Kristian
    Theissen, Jessica
    Westermann, Frank
    Vandesompele, Jo
    Speleman, Frank
    Berthold, Frank
    Eggert, Angelika
    Brors, Benedikt
    Hero, Barbara
    Schramm, Alexander
    Fischer, Matthias
    CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5082 - 5092
  • [45] A Semisynthetic Eph Receptor Tyrosine Kinase Provides Insight into Ligand-Induced Kinase Activation
    Singla, Nikhil
    Erdjument-Bromage, Hediye
    Himanen, Juha P.
    Muir, Tom W.
    Nikolov, Dimitar B.
    CHEMISTRY & BIOLOGY, 2011, 18 (03): : 361 - 371
  • [46] Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer
    Sankhe, Kaksha
    Prabhu, Arati
    Khan, Tabassum
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (01) : 73 - 93
  • [47] Tyrosine kinase receptor RON in human pancreatic cancer - Expression, function, and validation as a target
    Camp, E. Ramsay
    Yang, Anthony
    Gray, Mike J.
    Fan, Fan
    Hamilton, Stanley R.
    Evans, Douglas B.
    Hooper, Andrea T.
    Pereira, Daniel S.
    Hicklin, Daniel J.
    Ellis, Lee M.
    CANCER, 2007, 109 (06) : 1030 - 1039
  • [48] Insight into the Inhibition of Drug-Resistant Mutants of the Receptor Tyrosine Kinase EGFR
    Engel, Julian
    Becker, Christian
    Lategahn, Jonas
    Keul, Marina
    Ketzer, Julia
    Muehlenberg, Thomas
    Kollipara, Laxmikanth
    Schultz-Fademrecht, Carsten
    Zahedi, Rene P.
    Bauer, Sebastian
    Rauh, Daniel
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (36) : 10909 - 10912
  • [49] ISOLATION AND CHARACTERIZATION OF THE HUMAN DTK RECEPTOR TYROSINE KINASE
    CROSIER, KE
    HALL, LR
    LEWIS, PM
    MORRIS, CM
    WOOD, CR
    MORRIS, JC
    CROSIER, PS
    GROWTH FACTORS, 1994, 11 (02) : 137 - 144
  • [50] Tyrosine protein kinase (Trk) receptor in human melanocytes
    Whang, KU
    Kim, HJ
    Lee, JH
    Park, JH
    Lee, JS
    Kim, YK
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 576 - 576
12345